Navigation Links
symplr and Vistar Join Forces to Create Healthcare Provider Management Software Leader
Date:5/18/2017

symplr®, a leading provider of software as a service (SaaS) based healthcare compliance and credentialing solutions, today announced it has joined forces with Vistar Technologies (Vistar), a leader in the development and support of provider management software for healthcare providers, managed care and payer organizations. The combined company is now a clear market leader in provider management software with the largest customer base, and most comprehensive product and service offerings.

Combined, the symplr and Vistar product portfolios create the broadest provider management software platform covering: credentialing, privileging, payer enrollment, event reporting, professional practice reporting, peer review, network management, contracting, recruiting, onboarding, provider relations management, quality management, and systems integration. The functionality of the combined provider management software platform supports all aspects of provider data management for healthcare delivery.

“Vistar has an excellent track record of success in delivering provider management solutions for the payer and managed care market, and we are excited to combine our product and customer portfolios with this highly regarded company,” said Rick Pleczko, President and CEO of symplr. “We are proud to now say that our combined company offers an unparalleled solution for healthcare facilities, managed care organizations, payers and providers.”

symplr now delivers software solutions to more than 4,000 healthcare organizations, enabling these organizations to efficiently and effectively manage their provider information to increase efficiency, mitigate risk, increase patient safety and improve quality of care.

“By listening to customer and market needs, Vistar and symplr have both established leadership positions in our respective markets,” said Myra Ameigh, President and CEO of Vistar Technologies. “We are excited to join forces with symplr to continue to offer our customers next generation provider management solutions - solutions that deliver integrated support for all constituents of the healthcare community.”

symplr is a portfolio company of The CapStreet Group and Pamlico Capital. Healthcare Growth Partners served as financial adviser to symplr, CapStreet and Pamlico. Bailey Southwell served as financial adviser to Vistar Technologies.

Neil Kallmeyer, Managing Partner at The CapStreet Group, stated, “The completion of the Vistar and symplr transaction represents symplr’s fifth transaction in less than three years. We continue to pursue acquisition opportunities to further expand symplr’s product offerings, solidifying the company's position as a leading compliance and credentialing company in the healthcare industry.”

Brian Chambers, Principal at Pamlico Capital, added, “With a focus on both the payer and provider sides of the market, we’re excited about the opportunity available to the combined company. We look forward to working with the symplr team to help further fuel their growth in the coming years.”

About Vistar Technologies
Vistar Technologies has been delivering state-of-the-art workflow solutions for provider and network management for many of the nation’s largest health plans and providers since 1997. Vistar’s solution serves as a central provider data repository for compliance, integration, quality analysis, data access and reporting. For more information or to contact Vistar Technologies, call (888) 266-4532 or visit http://www.vistartech.com

About symplr
Founded in 2006, symplr is an industry leader in compliance and credentialing Software as a Service solutions that help healthcare organizations mitigate risk and ensure compliance. symplr , has a single mission: to make healthcare compliance and credentialing simpler for all constituents of the healthcare community. For more information or to contact symplr, visit http://www.symplr.com/ or (866) 373-9725.

About The CapStreet Group
The CapStreet Group is a private equity firm founded in 1990 that invests in owner-managed, middle market companies headquartered in Texas and surrounding states. CapStreet targets companies operating in the diversified business service, industrial distribution and industrial manufacturing sectors, and partners with management teams and existing owners to accelerate growth and improve profitability. For additional information, please visit http://www.capstreet.com.

About Pamlico Capital
Pamlico Capital is a private equity firm founded in 1988 that invests in lower middle market companies in the U.S. Pamlico Capital seeks control-oriented growth equity investments of up to $100 million alongside proven management teams in its target industries: business & technology services, communications, and healthcare. Since inception, the firm, based in Charlotte, NC, has invested over $2.5 billion. For additional information, please visit http://www.pamlicocapital.com.

Read the full story at http://www.prweb.com/releases/2017/05/prweb14347664.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Patrick Horine Shows How Accreditation Enables Process Improvement In symplr Webcast
2. Brian Betner Outlines Peer Review Benefits, Challenges in symplr Webcast
3. symplr Shares How to Achieve Payor Enrollment Success in symplr Monthly Webcast Series
4. symplr Appoints New Chief Financial Officer
5. symplr and Cactus Software Merge To Form Leader In Healthcare Provider Credentialing Software
6. symplr Discusses How Automation Benefits Medical Staff Services Professionals In Monthly Webcast Series
7. symplr Webcast Provides Seven Best Practices to Improve Healthcare Technology Adoption
8. symplr Continues Discussion on How Automation Benefits Medical Staff Services Professionals In Second Webcast
9. Tracey Meyer Promoted to Vice President, Product Management at symplr
10. symplr Healthcare Provider Management Roadshow Stops in Los Angeles
11. Julie Walker Joins symplr as Vice President, General Manager of Vendor Credentialing Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2017)... ... 22, 2017 , ... “To Walk Away”: a captivating and romantic sequel ... Koontz. “To Walk Away” is the creation of published author, Larry R. Sherman, a ... manuscripts in chemistry and religion, as well as four novels. , Though the ...
(Date:8/22/2017)... ... August 22, 2017 , ... “Covert Awakening”: Walid’s spiritual ... published author, Julianne Hale, a consultant for the Intelligence Community. For more ... on the Near East region. Julianne has written hundreds of reports for ...
(Date:8/22/2017)... (PRWEB) , ... August 22, 2017 , ... TopConsumerReviews.com recently ... to fight Fatigue . , As the stress of modern life continually makes ... the pace. Constant use of artificial stimulants can trap people in vicious high/low cycles ...
(Date:8/21/2017)... ... , ... PracticeMatch, a company that provides online resources , job ... practitioners like nurse practitioners and physician assistants , will conduct its ... year. The online career fairs will allow job seekers to connect with healthcare employers ...
(Date:8/21/2017)... ... August 21, 2017 , ... Los ... plastic surgery fellows for academic year 2017-2018, Christina M. Busuito, M.D. and Lukasz ... completed residency in Plastic and Reconstructive Surgery. The candidate will have the ...
Breaking Medicine News(10 mins):
(Date:7/26/2017)... E.I. Medical Imaging (EIMI) has partnered with ... design the worlds first ultrasound system to be used underwater ... habitat. In preparation for a piece produced by Icon ... Dr. Guttridge approached EIMI with the idea of an underwater ... sharks underwater. EIMI ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals ... of our clinical trial evaluating Altemia TM , an ... (SCA) and Sickle Cell Disease (SCD). The SCOT Trial, ... the efficacy and safety of Altemia TM in ... conducted under US IND 125274. ...
(Date:7/25/2017)... CAMBRIDGE, Massachusetts , July 25, 2017 The ... treat rare nervous system diseases, has concluded a worldwide license ... the drug SOM0226 against transthyretin amyloidosis (ATTR). Before this licensing ... in a Phase 2 study conducted in Europe ... the United States ...
Breaking Medicine Technology: